ArticleClinical cancer research : an official journal of the American Association for Cancer Research2011

Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-hodgkin lymphoma.

Steven I Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.